chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At the time of my flu shot, I was a little over 8 wks pregnant. I saw the baby on an ultrasound 3 days before- we were told it looked healthy, strong hb (178) and my pregnancy should be excellent. I got the flu shot as strongly advised by my nurse 3 days later (after stressing my concerns and stating that I never had the flu in my life, nor have I ever received a flu vaccine). I was told it was critical for my baby, so I received it. 3 days after that, Monday 11/15, I started cramping and bleeding. I took myself to the ER, and was told I may be having a miscarriage. The following day, Tuesday 11/16 an ultrasound confirmed the worst- I miscarried.
Patient received booster shot of Moderna. Previously had two Pfizer shots. About 7 minutes into her observation she began experiencing chest ache at about 1 to 2/10. VS were 143/76 and 132/80, HR 72, 98%. Patient wanted to go to ED to get further workup because she is concerned about side effects of COVID vaccine related to myocarditis.
Flu like symptom; Flashes; This spontaneous case was reported and describes the occurrence of INFLUENZA LIKE ILLNESS and HOT FLUSH in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included LYRICA and BACTRIM for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced HOT FLUSH. On 23-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS. At the time of the report, INFLUENZA LIKE ILLNESS and HOT FLUSH outcome was unknown. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact.
This spontaneous report as received from a certified medical assistant refers to unspecified number of patients of unknown ages and genders who on an unknown dates were vaccinated with an improperly stored doses of (Oka-Merck) PROQUAD (dose, lot #, expiration date and route were not reported). No adverse effects reported. It was unknown if the patient sought medical attention. This is one of several reports from the same source. Additional information has been requested.
Narrative: COVID infection following COVID vaccine series 03/09, Pfizer, dose #1 03/31, Pfizer, dose #2 08/24 HOMOCYSTEINE: 16.4 08/31 pt admit to ED cc: malaise dx: COVID 19 LOS: 1 day 08/31 CXR impression: Support devices: None identified Mediastinum: Normal cardiac size. No central pulmonary vascular enlargement. Lungs and pleura: No dense consolidation or pleural effusion is identified Bones: Within normal limits 08/31 COVID swab, result: detected 08/31 COVID-19 ANTIGEN: not detected 08/31 SARS-COV-2 Variant Sequencing result: pending 08/31 pt cc: cough, fatigue, headache, myalgias, rhinorrhea, exposure: unknown
p/ pt recv vax 7 days later pt devel red, bumpy rash on face, stomach & back.
This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date.) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date.). On 09-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date.) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Treatment information was unknown. It was reported that the vials were stored in the freezer and taken out of the freezer and placed in the refrigerator on the date of administration. The vials did not undergo any temperature excursions.
Vomiting after any and every type of feeding of normally tolerated Elecare formula in 6 month old infant baby girl occurred at approximately 6 hours after receiving these three vaccines. Beginning Thursday 9/19 at approximately 5PM EST.  Contacted pediatrician that administered vaccines the following day on Friday 9/20 and did not receive adequate care or medical guidance. My husband and I have thought about moving the patient to a new pediatrician and made a follow up call on Friday 9/20 to Dr. We brought patient to Dr. at 1:30PM on Friday 9/20 where she was evaluated. As this was not yet even 24 hours of the vomiting, we were sent home for monitoring. Dr remained in close contact through the next 24 hours through to Saturday 9/21 where patient continued to vomit. Saturday late afternoon/early evening 9/21 we decided in partnership with Dr to bring patient to the ER at Medical Center for the primary reason to assess dehydration levels and rule out any immediate medical or surgical emergency. We were discharged Saturday 9/21 due to no surgical emergency and to keep giving pedialyte to patient through a bottle. We continued to monitor patient Saturday night through Monday 9/23 with following up with the Doctor for medical guidance, Bringing patient to an allergist appointment Monday 9/23 to rule out an my potential allergic reactions. Throughout this entire time, patient has continued vomiting after eating. Fast forward as my form time is expiring- we went back to hospital ER Monday evening and were admitted. It is Thursday 9/26 and still here in the hospital. The doctors will have exact findings but everything is pointing to complications from a viral infection. Patient has to have many points of radiation through xrays and ultrasound and an Upper GI study.
Called to schedule second vaccine and daughter reports that he died on01/19/2021 with "COVID"
Aching increased in left arm, encompassing entire arm, axilla times 2 day gradually diminished over 1 week.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) lot # K010338, expiration date 22-JUL-2016 or lot # K026385, expiration date 15-DEC-2016 (dose and route of administration were not reported). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
This case was reported by a nurse via sales rep and described the occurrence of fever in a 17-year-old male patient who received BEXSERO for prophylaxis. Co-suspect products included HAVRIX for prophylaxis, MENVEO for prophylaxis, Varicella vaccine for prophylaxis and GARDASIL 9 for prophylaxis. On 25th July 2018, the patient received BEXSERO, HAVRIX, MENVEO, Varicella vaccine and GARDASIL 9 at an unknown dose and frequency. On 25th July 2018, less than a day after receiving BEXSERO, HAVRIX, MENVEO and Varicella vaccine, the patient experienced fever, fatigue, lower extremities weakness of and chills. The patient was treated with ibuprofen. On an unknown date, the outcome of the fever and chills were recovered/resolved and the outcome of the fatigue and lower extremities weakness of were recovering/resolving. It was unknown if the reporter considered the fever, fatigue, lower extremities weakness of and chills to be related to BEXSERO, HAVRIX, MENVEO and Varicella vaccine. Additional information was reported as follows: The healthcare professional reported that the patient was vaccinated with 5 vaccines, each vaccinated separately but on the same day. The patient called later on the same day of vaccination and experienced low grade fever of 99.6 degree F, along with chills, fatigue and leg weakness. The patient was instructed to take Ibuprofen as directed by the healthcare professional and take rest. On the next day of the vaccination, the healthcare professional called the patient and spoke to the patient's father and he stated that the patient was feeling much better after rest. Where Ibuprofen and fluids helped and the patient's symptoms were resolving.
While waiting in the car during post drive-up vaccine clinic observation period, patient developed itching in hands and hoarsness in throat.  No difficulty breathing.  No swelling of throat, lips or tongue.  No hives.  Vital signs were normal including oxygenation.  50mg Oral Benadryl was administered and improvement began within 10 minutes.  30 minutes after benadryl, hoarsness was gone and itching decreased.  45 minutes after benadryl, all symptoms were gone and patient was released from care by telehospitalist.
The pt had a large, red, indurated area on left arm. It was reported to be hot and itchy. Pt's MD instructed to use Benadryl and ice packs. The symptoms resolved as of 03/28/2002 at 3:30pm.
her arm sores; her back really hurts.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), administration date 04Mar2021 (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. Relevant medical history included: "arthritis on her back" (unspecified if ongoing); "dental surgery" (unspecified if ongoing). Concomitant medication(s) included: TYLENOL; HYDROCODONE. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "unknown", described as "her arm sores"; BACK PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "her back really hurts.". Additional information: The patient has been using paracetamol (TYLENOL) and hydrocodone for 2 weeks. The patient wanted to know if she could use paracetamol as she read that it could interfere with the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A couple hours after receiving the second dose of the Pfizer vaccine, I suddenly passed out (syncope) and hit my head as I lost consciousness while home alone. I went to the ER where blood, urine, and orthostatic tests were performed. Head injury was mild and without compilation. I was given an IV for fluids to recover from dehydration and then discharged.
This spontaneous report as received from a registered nurse refers to a 51 years old patient. On 11-JUN-2013 the patient inadvertently received VARIVAX (Merck) (0.5ml, once) (lot # H016600, expiry date 05-SEP-2014) subcutaneously instead of ZOSTAVAX which was planned. No adverse effects reported. The reporter stated physician intended to revaccinate with ZOSTAVAX at an unspecified time in the future. It was unspecified if the patient had sought medical attention. This is one of several reports from same source. Additional information has been requested.
Within 15 minutes of the shot, I became extremely weak in my muscles. In the middle of the night I had a fever of 103 and couldn't stop shaking, it was so painful. That was the weirdest thing I ever experienced in my life. I had three blankets and a robe on and couldn't stop trembling. There was pain all over my body, I had to wear a dress to the hospital because I couldn't put on pants because of the pain. At the ER, I was given an injection of Toradol and the pain was gone within 20 minutes.
We received msg from mother 8-12-10. RN reached via phone on 8-13-10, mother reported edema to lower (L) arm "soft-ball size" stated she was going to ER to have evaluated. Phone calls made on 8-25-10 x 2, 8-27-10 reached mother who reported edema decreased & is now resolved, stated they did not go to ER as planned. Denied any lasting effect, reported "he is fine now".
Head down clenched up, stiff, eyes rolling back in head, wet her pants, 5 minutes after event fell asleep.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 16-FEB-2015, the patient was vaccinated with improperly stored MMR II lot # K008814 and 19-JUN-2016 (unknown strength and route). Concomitant medications were not reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOTENSION 12/14/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
About week and half late got my period and was very heavy. Have not had period in  a year. Heavy flow, cramping like when I was younger.
I had a small red bump at injection site. I had fatigue and felt like I was coming down with a cold. The same night I woke up with a sore throat and a runny nose with a slight sore throat. 2 days later I had a 100-degree fever with some shortness of breath. Felt like a really nasty cold. After recovering, I developed a rash located on my abdomen to my spin, arms and head.
migraine headaches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 04Mar2021 17:00 (Batch/Lot number: unknown) at the age of 67 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Autoimmune disease , Lupus like high ANA" (ongoing), notes: Onset date: Childhood; "Autoimmune disease , Lupus like high ANA" (ongoing), notes: Onset date: Childhood; "Breast Cancer", start date: Nov2012, stop date: Jan2013, notes: Pertinent details: No recurrence; "High blood pressure" (unspecified if ongoing); "Anxiety" (unspecified if ongoing), notes: Anxiety + treatment for flares; "Hot flashes" (unspecified if ongoing); "Sleep aid" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE taken for hypertension, start date: 2020 (ongoing); DIAZEPAM taken for anxiety, start date: Oct1996 (ongoing); ESTRADIOL taken for hot flush, sleep disorder, start date: Jun2019 (ongoing). Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Time: Approx. 2:00 pm PST, Anatomical site of injection: left shoulder (Arm), Route of administration: intramuscular, Lot/Batch number: EL9265), administration date: 07Feb2021, for COVID-19 Immunisation, reaction(s): "Numbness in left hand, arm", "Numbness in lower leg", "Numbness in bottom of feet". The following information was reported: MIGRAINE (non-serious), outcome "unknown", described as "migraine headaches". The event "migraine headaches" was evaluated at the emergency room visit. Therapeutic measures were taken as a result of migraine.  Additional information: The four weeks after 2nd dose, patient started to get migraine headaches. The patient had the worst headache patient had ever had mostly on left side of head + face. patient went to emergency on 30Mar2021, was treated + released. Had been taking Tylenol everyday since.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information was received from an attorney regarding a case in litigation concerning a female patient of unknown age. Medical history, concurrent conditions and concomitant medications were not provided. In or about 06-FEB-2013, the patient was inoculated at a physician office with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 09-FEB-2013, the patient was treated at a physician office by Physician Assistant for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. The patient has been prescribed VALTREX for management of her painful symptoms. As a direct an proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX for long term prevention of shingles. The patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information has been requested.
I was informed by patient's parents that the patient had a febrile seizure the evening the vaccines were administered.
not sure right arm red inflamed , itchy, rashy  this is January  dose give in November  possible cellulitis possible unknown   lasted close to two weeks
sick and feverish; diarrhea; stomach crumps/ stomach issues; sick and feverish,99°F fever,the fever is unusual,fever of 101.6°F around 2 to 3 am; vomiting/ throwing up; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (sick and feverish,99°F fever,the fever is unusual,fever of 101.6°F around 2 to 3 am), VOMITING (vomiting/ throwing up), ILLNESS (sick and feverish), DIARRHOEA (diarrhea) and ABDOMINAL PAIN UPPER (stomach crumps/ stomach issues) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03ML20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021 at 4:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (sick and feverish,99°F fever,the fever is unusual,fever of 101.6°F around 2 to 3 am), ILLNESS (sick and feverish), DIARRHOEA (diarrhea) and ABDOMINAL PAIN UPPER (stomach crumps/ stomach issues). 10-Feb-2021, the patient experienced VOMITING (vomiting/ throwing up). The patient was treated with PARACETAMOL (TYLENOL) in February 2021 for Adverse event, at a dose of UNK dosage form. At the time of the report, PYREXIA (sick and feverish,99°F fever,the fever is unusual,fever of 101.6°F around 2 to 3 am), VOMITING (vomiting/ throwing up), ILLNESS (sick and feverish), DIARRHOEA (diarrhea) and ABDOMINAL PAIN UPPER (stomach crumps/ stomach issues) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: 101.6 101.6 degree F. On 12-Feb-2021, Body temperature: 99 (High) 99 degree F 97 degree F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. The patient took vaccine around 4 or 5 PM on 09-Feb-2021 and by 2or 3 AM the patient started experiencing the events. On 12-Feb-2021 the symptoms were the worst that 11-Feb-2021 but better than the other days. It was reported that Tylenol did help.
Patient described feeling facial numbness and chest discomfort and feeling anxious Patient seen by medical response team and provided with water Patient refused medical transport and signed AMA form Patient will be driven home by family
extreme confusion/ She had no idea where she was; her legs were painful; she woke up and it took her 13 minutes to walk from the bed to the toilet/ hardly walk; This case was reported by a consumer via call center representative and described the occurrence of confusion in a 79-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of somnolence (1st dose received on an unknown date, refer case US2020011308). Concurrent medical conditions included hip discomfort and sulfonamide allergy.   On 14th January 2020, the patient received the 2nd dose of Shingrix. On 15th January 2020, 1 days after receiving Shingrix, the patient experienced confusion, leg pain and walking difficulty. On an unknown date, the outcome of the confusion, leg pain and walking difficulty were recovered/resolved.   It was unknown if the reporter considered the confusion, leg pain and walking difficulty to be related to Shingrix.  Additional details were provided as follows: After the 2nd dose of Shingrix, the patient had extreme confusion. The confusion lasted from about 9 am until noon the next day of the vaccine. The next morning of having the vaccine, patient woke up and it took her 13 minutes to walk from the bed to the toilet.she had no idea where she was. The patient husband said she looked like a zombie. The patient legs were painful and she could hardly walk. The patient did not have this symptom anymore. Consent to follow up was provided.
CHIEF COMPLAINT:   pt c/o dizziness and abd pain and left hip pain starting yesterday.  Pt had hernia repaired Wednesday by Dr.  -fevers.  Pt appears pale and states he's lethargic.  pt states no traumas or falls to hip.  On coumadin.   HISTORY OF PRESENT ILLNESS:     81-year-old male past medical history as below presents now postop day 4 bilateral inguinal hernia repair and umbilical hernia repair with Dr.  with severe left lower quadrant abdominal pain.  On arrival to ED patient found to be in A. fib with RVR rate to the 170s.  Hypotensive to 70s systolic.  No modifying factors reported.  Reports anorexia for the past 1 to 2 days not eating or drinking.  Symptoms severe in severity.  Acute in duration.
vaccines are kept frozen until they are ready for adminstration which means they would be in the fridege about 1 to 3 days; Moderna vaccine beyond the use date and or expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine beyond the use date and or expired) and PRODUCT STORAGE ERROR (vaccines are kept frozen until they are ready for adminstration which means they would be in the fridege about 1 to 3 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine beyond the use date and or expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccines are kept frozen until they are ready for adminstration which means they would be in the fridege about 1 to 3 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine beyond the use date and or expired) and PRODUCT STORAGE ERROR (vaccines are kept frozen until they are ready for adminstration which means they would be in the fridege about 1 to 3 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment medication was not reported.
I have been experiencing pain in the upper left arm  for a few months now. When I researched about it, I came across some links which suggested that it could be due to flu vaccine. The symptoms include pain when I move my left arm in certain directions. I also feel my arm has lost some load-bearing capacity.  I cannot think of any other cause for this pain. I have not been given any other injection in my left arm since vaccination.